State Street Corp Windtree Therapeutics Inc Transaction History

State Street Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.14 - $6.9 $2,837 - $139,863	-20,270 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.94 - $1.6 $911 - $1,552	970 Added 5.03%	20,270 $23,000
Q2 2021 Aug 16, 2021	BUY	$1.68 - $2.79 $32,424 - $53,847	19,300 New	19,300 $44,000

4.09K

Ticker WINT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,627,900
Market Cap $97.4M
Description
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.